Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;17(6):687-94.
doi: 10.1038/ni.3422. Epub 2016 Apr 18.

Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense

Affiliations
Free article

Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense

Taisho Yamada et al. Nat Immunol. 2016 Jun.
Free article

Abstract

Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the toxic activity of many environmental xenobiotics. However, its role in innate immune responses during viral infection is not fully understood. Here we demonstrate that constitutive AHR signaling negatively regulates the type I interferon (IFN-I) response during infection with various types of virus. Virus-induced IFN-β production was enhanced in AHR-deficient cells and mice and resulted in restricted viral replication. We found that AHR upregulates expression of the ADP-ribosylase TIPARP, which in turn causes downregulation of the IFN-I response. Mechanistically, TIPARP interacted with the kinase TBK1 and suppressed its activity by ADP-ribosylation. Thus, this study reveals the physiological importance of endogenous activation of AHR signaling in shaping the IFN-I-mediated innate response and, further, suggests that the AHR-TIPARP axis is a potential therapeutic target for enhancing antiviral responses.

PubMed Disclaimer

References

    1. Trends Pharmacol Sci. 2013 Feb;34(2):136-43 - PubMed
    1. Microbiol Immunol. 2003;47(5):363-70 - PubMed
    1. Nat Immunol. 2011 Jan;12 (1):37-44 - PubMed
    1. Annu Rev Immunol. 2014;32:403-32 - PubMed
    1. Immunity. 2013 May 23;38(5):855-69 - PubMed

Publication types

Substances